2.3(top 20%)
impact factor
9.8K(top 2%)
papers
236.5K(top 2%)
citations
151(top 2%)
h-index
2.4(top 20%)
impact factor
11.1K
all documents
245.7K
doc citations
228(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1IMAGE ARTIFACTS IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHYRetina2015879
2ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHYRetina2009855
3DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina2006753
4IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)Retina1990743
5RETINAL ANGIOMATOUS PROLIFERATION IN AGE-RELATED MACULAR DEGENERATIONRetina2001690
6ANATOMICAL CORRELATES TO THE BANDS SEEN IN THE OUTER RETINA BY OPTICAL COHERENCE TOMOGRAPHYRetina2011639
7INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATIONRetina2006603
8INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHYRetina1995575
9TRANSCONJUNCTIVAL SUTURELESS 23-GAUGE VITRECTOMYRetina2005547
10EVEREST STUDYRetina2012523
11RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEWRetina2004520
12FUNDUS AUTOFLUORESCENCE IMAGINGRetina2008492
13INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY VITREOUS HEMORRHAGERetina2006484
14SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina2006484
15PATHOLOGIC FINDINGS IN PATHOLOGIC MYOPIARetina1992459
16INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF MACULAR EDEMA IN CENTRAL RETINAL VEIN OCCLUSIONRetina2006456
17INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina2000429
18INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR PERSISTENT DIFFUSE DIABETIC MACULAR EDEMARetina2006423
19PACHYCHOROID PIGMENT EPITHELIOPATHYRetina2013421
20INDOCYANINE GREEN VIDEOANGIOGRAPHY OF OLDER PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHYRetina1996415
21PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina2002411
22DIGITAL INDOCYANINE GREEN VIDEOANGIOGRAPHY AND CHOROIDAL NEOVASCULARIZATIONRetina1992407
23NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTSRetina2010402
24PACHYCHOROID NEOVASCULOPATHYRetina2015401
25ENLARGEMENT OF FOVEAL AVASCULAR ZONE IN DIABETIC EYES EVALUATED BY EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHYRetina2015394
26RETINAL VASCULAR PERFUSION DENSITY MAPPING USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN NORMALS AND DIABETIC RETINOPATHY PATIENTSRetina2015394
27INDOCYANINE GREEN ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY FOR TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHYRetina2003391
28Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration?Retina2010365
29META-ANALYSIS OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTSRetina2011361
30FACTORS ASSOCIATED WITH REDUCED VISUAL ACUITY DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHYRetina2002358
31ELECTROPHYSIOLOGIC AND RETINAL PENETRATION STUDIES FOLLOWING INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN)Retina2006355
32TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHYRetina1987351
33EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONSRetina2004350
34REGRESSION OF RETINAL AND IRIS NEOVASCULARIZATION AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENTRetina2006341
35RESOLUTION OF DIABETIC MACULAR EDEMA AFTER SURGICAL REMOVAL OF THE POSTERIOR HYALOID AND THE INNER LIMITING MEMBRANERetina2000333
36TRIAMCINOLONE ACETONIDE AS AN AID TO VISUALIZATION OF THE VITREOUS AND THE POSTERIOR HYALOID DURING PARS PLANA VITRECTOMYRetina2000333
37RADIAL OPTIC NEUROTOMY FOR CENTRAL RETINAL VEIN OCCLUSIONRetina2001332
38SUBRETINAL DRUSENOID DEPOSITS IN NON-NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina2013330
39DETECTION OF MICROVASCULAR CHANGES IN EYES OF PATIENTS WITH DIABETES BUT NOT CLINICAL DIABETIC RETINOPATHY USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHYRetina2015330
40Photodynamic Therapy for Chronic Central Serous ChorioretinopathyRetina2003329
41SUBFOVEAL CHOROIDAL THICKNESS AFTER TREATMENT OF VOGT–KOYANAGI–HARADA DISEASERetina2011328
42THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASERetina2005325
43EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHYRetina2016325
44OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF DIABETIC RETINOPATHYRetina2015324
45DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTSRetina2011321
46IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)Retina2012312
47DRUSEN CHARACTERIZATION WITH MULTIMODAL IMAGINGRetina2010311
48CORRELATION OF FOVEAL AVASCULAR ZONE SIZE WITH FOVEAL MORPHOLOGY IN NORMAL EYES USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHYRetina2015306
49Idiopathic polypoidal choroidal vasculopathy (IPCV)Retina1990305
50ULTRA–WIDE-FIELD ANGIOGRAPHY IMPROVES THE DETECTION AND CLASSIFICATION OF DIABETIC RETINOPATHYRetina2012301